Vivek Bhalla, MD

Nephrologist - Kidney specialist

Assistant Professor of Medicine (Nephrology)
4.9 out of 5
42 Patient Ratings
6 Patient Comments

Kidney Clinic (Nephrology)

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6961
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Fellowship: UCSF-Graduate Medical Education (2005) CA

Residency: Harbor-UCLA Medical Center (2001) CA

Medical Education: University of California San Diego (1998) CA

Fellowship, Univ of California San Francisco, Nephrology (2005)

Residency, Harbor-UCLA Medical Center, Internal Medicine (2001)

M.D., Univ of California San Diego, Medicine (1998)

B.S., Univ of California Berkeley, Electrical Engineering (1994)

Honors & Awards

Henry J Kaiser Family Foundation Award for Excellence in Preclinical Teaching, Stanford University School of Medicine (2012)

Carl W. Gottschalk Research Grant, American Society of Nephrology (2010-2012)

Shaul G. Massry Young InvestigatorÂ’s Award, National Kidney Foundation (2008)

Teaching Awardee, Halie T. Debas Academy of Medical Educators, UCSF (2007)

Mentored Clinical Scientist Award, NIH/NIDDK (2005)

Fellow, American Society of Nephrology (2003)

Patient Ratings and Comments

4.9

Friendliness

5.0

Recommended to others

4.9

Explanations

4.9

Listens

4.9

Includes you in decisions

4.9

Clear Communication

5.0

Confidence in your doctor

3.9

Wait times

SHC Patient, Nov 2014

Very good experience, overall.

SHC Patient, May 2014

I am extremely pleased with Dr. Bhalla.

SHC Patient, May 2014

Dr. Bhalla is always very prepared when I arrive. He has already gone over test results, etc. He is a great doctor!

SHC Patient, Apr 2014

Good experience.

View all 6 patient comments

Is there a sweet spot for nrf2 activation in the treatment of diabetic kidney disease?
Hall, E. T., & Bhalla, V. (2014). Is there a sweet spot for nrf2 activation in the treatment of diabetic kidney disease?. Diabetes, 63(9), 2904-2905.

Racial/Ethnic Differences in the Prevalence of Proteinuric and Nonproteinuric Diabetic Kidney Disease
Bhalla, V., Zhao, B., Azar, K. Mj., Wang, E. J., Choi, S., & Palaniappan, L. P. (2013). Racial/Ethnic Differences in the Prevalence of Proteinuric and Nonproteinuric Diabetic Kidney Disease. DIABETES CARE, 36(5), 1215-1221.

A transcriptional blueprint for human and murine diabetic kidney disease.
Bhalla, V., Velez, M.-G., & Chertow, G. M. (2013). A transcriptional blueprint for human and murine diabetic kidney disease. Diabetes, 62(1), 31-33.

Low-Level Lead Exposure and the Prevalence of Gout An Observational Study
Krishnan, E., Lingala, B., & Bhalla, V. (2012). Low-Level Lead Exposure and the Prevalence of Gout An Observational Study. ANNALS OF INTERNAL MEDICINE, 157(4), 233-?.

Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2) Regulation by 14-3-3 Protein Binding at Canonical Serum and Glucocorticoid Kinase 1 (SGK1) Phosphorylation Sites
Chandran, S., Li, H., Dong, W., Krasinska, K., Adams, C., & Bhalla, V. (2011). Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2) Regulation by 14-3-3 Protein Binding at Canonical Serum and Glucocorticoid Kinase 1 (SGK1) Phosphorylation Sites. JOURNAL OF BIOLOGICAL CHEMISTRY, 286(43), 37830-37840.

In diabetic nephropathy, high doses of vitamin B decrease glomerular filtration rate and increase risk of the composite outcome of a vascular event or all-cause mortality compared with placebo.
Bhalla, V. (2011). In diabetic nephropathy, high doses of vitamin B decrease glomerular filtration rate and increase risk of the composite outcome of a vascular event or all-cause mortality compared with placebo. Evidence-based medicine, 16(1), 14-15.

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Esler, M. D., Krum, H., Sobotka, P. A., Schlaich, M. P., Schmieder, R. E., & Massaro, J. M. (2010). Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. LANCET, 376(9756), 1903-1909.

Phosphopeptide Screen Uncovers Novel Phosphorylation Sites of Nedd4-2 That Potentiate Its Inhibition of the Epithelial Na+ Channel
Hallows, K. R., Bhalla, V., Oyster, N. M., Wijngaarden, M. A., Lee, J. K., & Pearce, D. (2010). Phosphopeptide Screen Uncovers Novel Phosphorylation Sites of Nedd4-2 That Potentiate Its Inhibition of the Epithelial Na+ Channel. JOURNAL OF BIOLOGICAL CHEMISTRY, 285(28), 21671-21678.

Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease
Prakash, S., Hernandez, G. T., Dujaili, I., & Bhalla, V. (2009). Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. NATURE REVIEWS NEPHROLOGY, 5(5), 297-300.

Melamine nephrotoxicity: an emerging epidemic in an era of globalization
Bhalla, V., Grimm, P. C., Chertow, G. M., & Pao, A. C. (2009). Melamine nephrotoxicity: an emerging epidemic in an era of globalization. KIDNEY INTERNATIONAL, 75(8), 774-779.

Mechanisms of ENaC regulation and clinical implications
Bhalla, V., & Hallows, K. R. (2008). Mechanisms of ENaC regulation and clinical implications. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(10), 1845-1854.

NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions
Pao, A. C., McCormick, J. A., Li, H., Siu, J., Govaerts, C., & Pearce, D. (2007). NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 292(6), F1741-F1750.

Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ
Bhalla, V., Soundararajan, R., Pao, A. C., Li, H., & Pearce, D. (2006). Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 291(4), F714-F721.

AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2
Bhalla, V., Oyster, N. M., Fitch, A. C., Wijngaarden, M. A., Neumann, D., & Hallows, K. R. (2006). AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2. JOURNAL OF BIOLOGICAL CHEMISTRY, 281(36), 26159-26169.

Serum- and glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 by inducing interaction with 14-3-3
Bhalla, V., Daidie, D., Li, H. Y., Pao, A. C., LaGrange, L. P., & Pearce, D. (2005). Serum- and glucocorticoid-regulated kinase 1 regulates ubiquitin ligase neural precursor cell-expressed, developmentally down-regulated protein 4-2 by inducing interaction with 14-3-3. MOLECULAR ENDOCRINOLOGY, 19(12), 3073-3084.

SGK1: A rapid aldosterone-induced regulator of renal sodium reabsorption
McCormick, J. A., Bhalla, V., Pao, A. C., & Pearce, D. (2005). SGK1: A rapid aldosterone-induced regulator of renal sodium reabsorption. PHYSIOLOGY, 20, 134-139.

Recurrent and de novo diabetic nephropathy in renal allografts
Bhalla, V., Nast, C. C., Stollenwerk, N., Tran, S., Barba, L., & Adler, S. G. (2003). Recurrent and de novo diabetic nephropathy in renal allografts. TRANSPLANTATION, 75(1), 66-71.

4.9 out of 5
42 Patient Ratings
6 Patient Comments

SHC Patient, Nov 2014

Very good experience, overall.

SHC Patient, May 2014

I am extremely pleased with Dr. Bhalla.

SHC Patient, May 2014

Dr. Bhalla is always very prepared when I arrive. He has already gone over test results, etc. He is a great doctor!

SHC Patient, Apr 2014

Good experience.

SHC Patient, Mar 2014

Dr. Bhalla - Excellent.

SHC Patient, Feb 2014

Very caring and professional doctor.